Synopsys, Inc. $SNPS Shares Purchased by Pacer Advisors Inc.

Pacer Advisors Inc. boosted its holdings in Synopsys, Inc. (NASDAQ:SNPS) by 16.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 30,570 shares of the semiconductor company’s stock after acquiring an additional 4,361 shares during the quarter. Pacer Advisors Inc.’s holdings in Synopsys were worth $15,083,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in SNPS. Saudi Central Bank bought a new stake in shares of Synopsys in the 1st quarter worth approximately $26,000. Independence Bank of Kentucky grew its position in Synopsys by 120.0% in the second quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after buying an additional 30 shares during the last quarter. Princeton Global Asset Management LLC increased its holdings in shares of Synopsys by 481.8% in the second quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock valued at $33,000 after buying an additional 53 shares in the last quarter. WPG Advisers LLC acquired a new stake in shares of Synopsys during the 1st quarter valued at $34,000. Finally, AlphaQuest LLC lifted its position in shares of Synopsys by 423.1% during the 2nd quarter. AlphaQuest LLC now owns 68 shares of the semiconductor company’s stock valued at $35,000 after acquiring an additional 55 shares during the last quarter. Institutional investors own 85.47% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on SNPS shares. Wells Fargo & Company lifted their target price on Synopsys from $445.00 to $500.00 and gave the stock an “equal weight” rating in a report on Thursday, December 11th. JPMorgan Chase & Co. lifted their price target on Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a research note on Thursday, December 11th. BNP Paribas started coverage on shares of Synopsys in a research note on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price objective for the company. Needham & Company LLC raised their target price on shares of Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Finally, Morgan Stanley boosted their price target on shares of Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a report on Friday, December 12th. Eleven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Synopsys presently has an average rating of “Moderate Buy” and a consensus target price of $562.13.

Synopsys News Roundup

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Analysts/commentary note Synopsys’ recent bounce and argue the shares could be attractive after the pullback; these narratives can support buying interest as investors re-evaluate valuation and growth prospects. Is Synopsys (SNPS) an Attractive Investment Choice?
• Positive Sentiment: Separate coverage focuses on an ~18% share rebound, asking whether the recovery leaves the stock undervalued — this kind of coverage can support momentum buyers. Synopsys (SNPS): Has the Recent 18% Share Price Rebound Left the Stock Undervalued?
• Neutral Sentiment: Reported short-interest data appears to show a 0-share figure and 0.0 days-to-cover — likely a data glitch and not a reliable signal for positioning. Treat this as non-actionable until confirmed by an exchange/shorts report.
• Negative Sentiment: Multiple law firms have announced class-action suits or investor alerts alleging securities fraud tied to a sharp prior stock drop; firms are soliciting lead plaintiffs with a looming Dec. 30, 2025 deadline. The alleged class period is Dec. 4, 2024 through Sept. 9, 2025; some filings cite a ~36% decline as the basis for claims. This concentrated legal publicity increases headline risk, potential litigation costs, and investor uncertainty — factors that can pressure the stock. Representative notices: KSF / Charles Foti 96-Hour Deadline Alert — BFA: Suit after 36% stock drop — Levi & Korsinsky notice

Insider Transactions at Synopsys

In related news, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the sale, the chief financial officer owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.62% of the company’s stock.

Synopsys Stock Performance

SNPS stock opened at $477.14 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. The stock has a market cap of $91.29 billion, a P/E ratio of 59.72, a P/E/G ratio of 3.97 and a beta of 1.16. The firm has a 50 day simple moving average of $437.58 and a 200 day simple moving average of $503.60. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, beating the consensus estimate of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.25 billion. During the same quarter in the prior year, the business earned $3.40 EPS. The company’s revenue for the quarter was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Research analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.